Your browser doesn't support javascript.
Predicting clinical outcomes among hospitalized COVID-19 patients using both local and published models.
Galanter, William; Rodríguez-Fernández, Jorge Mario; Chow, Kevin; Harford, Samuel; Kochendorfer, Karl M; Pishgar, Maryam; Theis, Julian; Zulueta, John; Darabi, Houshang.
  • Galanter W; Departments of Medicine and Pharmacy Systems, Outcomes and Policy, University of Illinois At Chicago (UIC), Chicago, USA. BillG@uic.edu.
  • Rodríguez-Fernández JM; Department of Neurology, Clinical Informatics Fellowship, UIC, Chicago, USA.
  • Chow K; College of Medicine, UIC, Chicago, USA.
  • Harford S; Department of Mechanical and Industrial Engineering, UIC, Chicago, USA.
  • Kochendorfer KM; Department of Family and Community Medicine, UIC, Chicago, USA.
  • Pishgar M; Department of Mechanical and Industrial Engineering, UIC, Chicago, USA.
  • Theis J; Department of Mechanical and Industrial Engineering, UIC, Chicago, USA.
  • Zulueta J; Department of Psychiatry, UIC, Chicago, USA.
  • Darabi H; Department of Mechanical and Industrial Engineering, UIC, Chicago, USA.
BMC Med Inform Decis Mak ; 21(1): 224, 2021 07 24.
Article in English | MEDLINE | ID: covidwho-1322935
ABSTRACT

BACKGROUND:

Many models are published which predict outcomes in hospitalized COVID-19 patients. The generalizability of many is unknown. We evaluated the performance of selected models from the literature and our own models to predict outcomes in patients at our institution.

METHODS:

We searched the literature for models predicting outcomes in inpatients with COVID-19. We produced models of mortality or criticality (mortality or ICU admission) in a development cohort. We tested external models which provided sufficient information and our models using a test cohort of our most recent patients. The performance of models was compared using the area under the receiver operator curve (AUC).

RESULTS:

Our literature review yielded 41 papers. Of those, 8 were found to have sufficient documentation and concordance with features available in our cohort to implement in our test cohort. All models were from Chinese patients. One model predicted criticality and seven mortality. Tested against the test cohort, internal models had an AUC of 0.84 (0.74-0.94) for mortality and 0.83 (0.76-0.90) for criticality. The best external model had an AUC of 0.89 (0.82-0.96) using three variables, another an AUC of 0.84 (0.78-0.91) using ten variables. AUC's ranged from 0.68 to 0.89. On average, models tested were unable to produce predictions in 27% of patients due to missing lab data.

CONCLUSION:

Despite differences in pandemic timeline, race, and socio-cultural healthcare context some models derived in China performed well. For healthcare organizations considering implementation of an external model, concordance between the features used in the model and features available in their own patients may be important. Analysis of both local and external models should be done to help decide on what prediction method is used to provide clinical decision support to clinicians treating COVID-19 patients as well as what lab tests should be included in order sets.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Reviews Limits: Humans Country/Region as subject: Asia Language: English Journal: BMC Med Inform Decis Mak Journal subject: Medical Informatics Year: 2021 Document Type: Article Affiliation country: S12911-021-01576-w

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Reviews Limits: Humans Country/Region as subject: Asia Language: English Journal: BMC Med Inform Decis Mak Journal subject: Medical Informatics Year: 2021 Document Type: Article Affiliation country: S12911-021-01576-w